Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

199 Outcomes after microvascular decompression for patients with trigeminal neuralgia and suspected multiple sclerosis.
Antioxidative enzymes activity and malondialdehyde concentration during mitoxantrone therapy in multiple sclerosis patients.
Oligodendroglial membrane dynamics in relation to myelin biogenesis.
Mitoxantrone repression of astrocyte activation: Relevance to multiple sclerosis.
Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis.
Interferon beta-1b in secondary progressive MS: a combined analysis of the two trials.
FDA Drug Safety Communication: FDA warns about case of rare brain infection PML with MS drug Tecfidera (dimethyl fumarate)
Individual oligodendrocytes have only a few hours in which to generate new myelin sheaths in vivo.
Evaluating epigenetic landmarks in the brain of multiple sclerosis patients: a contribution to the current debate on disease pathogenesis.
Oligodendrogenesis and myelinogenesis during postnatal development effect of glatiramer acetate.
[The effect of flupirtine, various analgesics and muscle relaxants on skeletal muscle tone in the conscious rat].
Dimethyl fumarate treatment alters circulating T helper cell subsets in multiple sclerosis.
Magnetic resonance imaging effects of interferon beta-1b in the BENEFIT study: integrated 2-year results.
Dimethyl fumarate (BG-12, Tecfidera) - NICE gives initial "no" decision
Influence of Previous Failed Antispasticity Therapy on the Efficacy and Tolerability of THC:CBD Oromucosal Spray for Multiple Sclerosis Spasticity.
Dysregulation of regulatory CD56(bright) NK cells/T cells interactions in multiple sclerosis.
Autoimmunity in visual loss.
Monoclonal antibodies in MS: mechanisms of action.
Oral Laquinimod for Multiple Sclerosis Treatment Significantly Reduced Disease Activity and Disability Progression While Providing Good Safety and Tolerability
European Medicines Agency, Scientific Discussion of MabCampath (alemtuzumab)
Interferon beta-1a long-term therapy related to pulmonary arterial hypertension in multiple sclerosis patients.
Gray matter SWI-filtered phase and atrophy are linked to disability in MS .
Treatment satisfaction in multiple sclerosis.
Interferon-beta(1b) treatment in neuromyelitis optica.
The influence of disease duration, clinical course, and immunosuppressive therapy on the synthesis of intrathecal oligoclonal IgG bands in multiple sclerosis.

Pages